India Glycols downgraded to sell amid valuation concerns
India Glycols has been downgraded to sell due to valuation and financial concerns. Despite a PAT of ₹1,383.1 cr and a 25.6% growth, modest sales growth and high debt levels raise red flags for investors.
after close1 source ↓written by the desknot a recommendation
- reflecting
- 25.6% growth
- over five years
- 7.9% CAGR
India Glycols has been downgraded to sell amid concerns over its long-term fundamentals. The company reported a PAT of ₹1,383.1 cr, reflecting a 25.6% growth. However, net sales growth has been modest at 7.9% CAGR over five years, with a Debt to EBITDA ratio of 3.21, indicating leverage risks.
Not investment advice. For informational purposes only.